Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

478 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pathogenic BRCA Variants as Biomarkers for Risk in Prostate Cancer.
McNevin CS, Cadoo K, Baird AM, Murchan P, Sheils O, McDermott R, Finn S. McNevin CS, et al. Among authors: finn s. Cancers (Basel). 2021 Nov 14;13(22):5697. doi: 10.3390/cancers13225697. Cancers (Basel). 2021. PMID: 34830851 Free PMC article. Review.
BRAF T1799A mutation occurring in a case of malignant struma ovarii.
Flavin R, Smyth P, Crotty P, Finn S, Cahill S, Denning K, Jinghuan Li, O'Regan E, O'Leary J, Sheils O. Flavin R, et al. Among authors: finn s. Int J Surg Pathol. 2007 Apr;15(2):116-20. doi: 10.1177/1066896906299131. Int J Surg Pathol. 2007. PMID: 17478764
RET/PTC rearrangement occurring in primary peritoneal carcinoma.
Flavin R, Jackl G, Finn S, Smyth P, Ring M, O'Regan E, Cahill S, Unger K, Denning K, Jinghuan Li, Aherne S, Tallini G, Gaffney E, O'Leary JJ, Zitzelsberger H, Sheils O. Flavin R, et al. Among authors: finn s. Int J Surg Pathol. 2009 Jun;17(3):187-97. doi: 10.1177/1066896908329593. Epub 2009 Jan 14. Int J Surg Pathol. 2009. PMID: 19147513
Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells.
Egan K, Crowley D, Smyth P, O'Toole S, Spillane C, Martin C, Gallagher M, Canney A, Norris L, Conlon N, McEvoy L, Ffrench B, Stordal B, Keegan H, Finn S, McEneaney V, Laios A, Ducrée J, Dunne E, Smith L, Berndt M, Sheils O, Kenny D, O'Leary J. Egan K, et al. Among authors: finn s. PLoS One. 2011;6(10):e26125. doi: 10.1371/journal.pone.0026125. Epub 2011 Oct 12. PLoS One. 2011. PMID: 22022533 Free PMC article.
Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening.
Laios A, Mohamed BM, Kelly L, Flavin R, Finn S, McEvoy L, Gallagher M, Martin C, Sheils O, Ring M, Davies A, Lawson M, Gleeson N, D'Arcy T, d'Adhemar C, Norris L, Langhe R, Saadeh FA, O'Leary JJ, O'Toole SA. Laios A, et al. Among authors: finn s. Int J Mol Sci. 2013 Jan 22;14(1):2085-103. doi: 10.3390/ijms14012085. Int J Mol Sci. 2013. PMID: 23340649 Free PMC article.
The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.
d'Adhemar CJ, Spillane CD, Gallagher MF, Bates M, Costello KM, Barry-O'Crowley J, Haley K, Kernan N, Murphy C, Smyth PC, O'Byrne K, Pennington S, Cooke AA, Ffrench B, Martin CM, O'Donnell D, Hennessy B, Stordal B, Finn S, McCann A, Gleeson N, D'Arcy T, Flood B, O'Neill LA, Sheils O, O'Toole S, O'Leary JJ. d'Adhemar CJ, et al. Among authors: finn s. PLoS One. 2014 Jun 30;9(6):e100816. doi: 10.1371/journal.pone.0100816. eCollection 2014. PLoS One. 2014. PMID: 24977712 Free PMC article.
The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial.
Sheill G, Brady L, Guinan E, Hayes B, Casey O, Greene J, Vlajnic T, Cahill F, Van Hemelrijck M, Peat N, Rudman S, Hussey J, Cunningham M, Grogan L, Lynch T, Manecksha RP, McCaffrey J, Mucci L, Sheils O, O'Leary J, O'Donnell DM, McDermott R, Finn S. Sheill G, et al. Among authors: finn s. Trials. 2017 Oct 4;18(1):456. doi: 10.1186/s13063-017-2201-3. Trials. 2017. PMID: 28978344 Free PMC article. Clinical Trial.
Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer.
Murphy K, Murphy BT, Boyce S, Flynn L, Gilgunn S, O'Rourke CJ, Rooney C, Stöckmann H, Walsh AL, Finn S, O'Kennedy RJ, O'Leary J, Pennington SR, Perry AS, Rudd PM, Saldova R, Sheils O, Shields DC, Watson RW. Murphy K, et al. Among authors: finn s. Mol Oncol. 2018 Sep;12(9):1513-1525. doi: 10.1002/1878-0261.12348. Epub 2018 Aug 7. Mol Oncol. 2018. PMID: 29927052 Free PMC article.
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?
Baird AM, Easty D, Jarzabek M, Shiels L, Soltermann A, Klebe S, Raeppel S, MacDonagh L, Wu C, Griggs K, Kirschner MB, Stanfill B, Nonaka D, Goparaju CM, Murer B, Fennell DA, O'Donnell DM, Barr MP, Mutti L, Reid G, Finn S, Cuffe S, Pass HI, Opitz I, Byrne AT, O'Byrne KJ, Gray SG. Baird AM, et al. Among authors: finn s. Front Endocrinol (Lausanne). 2019 Feb 26;10:89. doi: 10.3389/fendo.2019.00089. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30863365 Free PMC article.
478 results